Will a contrarian leader be good for the Food and Drug Administration? Which ATTR-CM drug will have the best launch? And what are the hosts making for their holiday dinners?
We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. STAT’s FDA reporter Lizzy Lawrence joins us to discuss her profile of Marty Makary, Trump’s nominee for FDA commissioner. Then, we discuss the results of Vertex’s latest pain drug trial, the medication launches to watch in 2025, and present our burning questions for the biopharma industry.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
